Krishnan V - Search Results

1

Hyaluronic acid conjugates for topical treatment of skin cancer lesions.

Krishnan V, Peng K, Sarode A, Prakash S, Zhao Z, Filippov SK, Todorova K, Sell BR, Lujano O, Bakre S, Pusuluri A, Vogus D, Tsai KY, Mandinova A, Mitragotri S. Krishnan V, et al. Sci Adv. 2021 Jun 11;7(24):eabe6627. doi: 10.1126/sciadv.abe6627. Print 2021 Jun. Sci Adv. 2021. PMID: 34117055 Free PMC article.

2

A hyaluronic acid conjugate engineered to synergistically and sequentially deliver gemcitabine and doxorubicin to treat triple negative breast cancer.

Vogus DR, Evans MA, Pusuluri A, Barajas A, Zhang M, Krishnan V, Nowak M, Menegatti S, Helgeson ME, Squires TM, Mitragotri S. Vogus DR, et al. Among authors: krishnan v. J Control Release. 2017 Dec 10;267:191-202. doi: 10.1016/j.jconrel.2017.08.016. Epub 2017 Aug 18. J Control Release. 2017. PMID: 28823957

3

Detachment of ligands from nanoparticle surface under flow and endothelial cell contact: Assessment using microfluidic devices.

Jarvis M, Arnold M, Ott J, Krishnan V, Pant K, Prabhakarpandian B, Mitragotri S. Jarvis M, et al. Among authors: krishnan v. Bioeng Transl Med. 2018 Apr 17;3(2):148-155. doi: 10.1002/btm2.10089. eCollection 2018 May. Bioeng Transl Med. 2018. PMID: 30065969 Free PMC article.

4

Treating Tumors at Low Drug Doses Using an Aptamer-Peptide Synergistic Drug Conjugate.

Pusuluri A, Krishnan V, Lensch V, Sarode A, Bunyan E, Vogus DR, Menegatti S, Soh HT, Mitragotri S. Pusuluri A, et al. Among authors: krishnan v. Angew Chem Int Ed Engl. 2019 Jan 28;58(5):1437-1441. doi: 10.1002/anie.201812650. Epub 2018 Dec 21. Angew Chem Int Ed Engl. 2019. PMID: 30537284

5

Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers.

Zhao Z, Ukidve A, Krishnan V, Mitragotri S. Zhao Z, et al. Among authors: krishnan v. Adv Drug Deliv Rev. 2019 Mar 15;143:3-21. doi: 10.1016/j.addr.2019.01.002. Epub 2019 Jan 11. Adv Drug Deliv Rev. 2019. PMID: 30639257 Review.

6

Nanocrystals: A perspective on translational research and clinical studies.

Jarvis M, Krishnan V, Mitragotri S. Jarvis M, et al. Among authors: krishnan v. Bioeng Transl Med. 2018 Dec 24;4(1):5-16. doi: 10.1002/btm2.10122. eCollection 2019 Jan. Bioeng Transl Med. 2018. PMID: 30680314 Free PMC article. Review.

7

Role of synergy and immunostimulation in design of chemotherapy combinations: An analysis of doxorubicin and camptothecin.

Pusuluri A, Krishnan V, Wu D, Shields CW 4th, Wang LW, Mitragotri S. Pusuluri A, et al. Among authors: krishnan v. Bioeng Transl Med. 2019 Jun 13;4(2):e10129. doi: 10.1002/btm2.10129. eCollection 2019 May. Bioeng Transl Med. 2019. PMID: 31249879 Free PMC article.

8

Shape effect in active targeting of nanoparticles to inflamed cerebral endothelium under static and flow conditions.

Da Silva-Candal A, Brown T, Krishnan V, Lopez-Loureiro I, Ávila-Gómez P, Pusuluri A, Pérez-Díaz A, Correa-Paz C, Hervella P, Castillo J, Mitragotri S, Campos F. Da Silva-Candal A, et al. Among authors: krishnan v. J Control Release. 2019 Sep 10;309:94-105. doi: 10.1016/j.jconrel.2019.07.026. Epub 2019 Jul 19. J Control Release. 2019. PMID: 31330214 Free article.

9

Design principles of drug combinations for chemotherapy.

Wu D, Pusuluri A, Vogus D, Krishnan V, Shields CW 4th, Kim J, Razmi A, Mitragotri S. Wu D, et al. Among authors: krishnan v. J Control Release. 2020 Jul 10;323:36-46. doi: 10.1016/j.jconrel.2020.04.018. Epub 2020 Apr 10. J Control Release. 2020. PMID: 32283210

10

Nanoparticles for topical drug delivery: Potential for skin cancer treatment.

Krishnan V, Mitragotri S. Krishnan V, et al. Adv Drug Deliv Rev. 2020 Jan 1;153:87-108. doi: 10.1016/j.addr.2020.05.011. Epub 2020 Jun 1. Adv Drug Deliv Rev. 2020. PMID: 32497707

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

975 results

Search Page